• Publications
  • Influence
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
BACKGROUND Hepatitis C virus (HCV) infection is highly prevalent among HIV-1-infected individuals, but its contribution to the morbidity and mortality of coinfected patients who receive potentExpand
  • 928
  • 26
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
CONTEXT Acquired immunodeficiency syndrome-related opportunistic illnesses (Ols) continue to occur after initiation of potent antiretroviral therapy in patients with human immunodeficiency virusExpand
  • 502
  • 21
  • PDF
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.
BACKGROUND Patterns of morbidity and mortality among human immunodeficiency virus (HIV)-infected individuals taking antiretroviral therapy are changing as a result of immune reconstitution andExpand
  • 482
  • 17
  • PDF
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
BACKGROUND Highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)-1 infection allows recovery of CD4 T lymphocytes. Few studies have explored the long-term T-lymphocyteExpand
  • 365
  • 16
  • PDF
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
Mortality among HIV‐infected persons is decreasing, and causes of death are changing. Classification of deaths is hampered because of low autopsy rates, frequent deaths outside of hospitals, andExpand
  • 275
  • 14
  • PDF
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
BACKGROUND Chronic liver disease in human immunodeficiency virus (HIV)-infected patients is mostly caused by hepatitis virus co-infection. Other reasons for chronic alanine aminotransferase (ALT)Expand
  • 99
  • 14
  • PDF
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.
Titers of lymphocytic choriomeningitis virus (LCMV) were determined on adherent fibroblast cell lines in 24- or 96-well plates. After absorption of virus by cells and 48 h incubation under aExpand
  • 432
  • 13
Immune reconstitution in HIV-infected patients.
The prognosis of patients infected with human immunodeficiency virus (HIV) type 1 has dramatically improved since the advent of potent antiretroviral therapies (ARTs), which have enabled sustainedExpand
  • 324
  • 13
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
Abstract Objectives: To examine trends in disease progression and survival among patients enrolled in the Swiss HIV cohort study during 1988–96 and to assess the influence of new antiretroviralExpand
  • 629
  • 11
Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
BACKGROUND Data on infections associated with cerebrospinal fluid (CSF) shunts among adults are limited. Therefore, we performed a retrospective study of shunt-associated infections in adults. Expand
  • 187
  • 10